OncoCyte Corp (OCX)
2.52
+0.07
(+2.86%)
USD |
NASDAQ |
Dec 09, 14:40
OncoCyte Price: 2.52 for Dec. 9, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Dec 06, 2024 | 2.38 | 2.50 | 2.347 | 2.45 | 44326.00 |
| Dec 05, 2024 | 2.39 | 2.44 | 1.98 | 2.30 | 611506.0 |
| Dec 04, 2024 | 2.37 | 2.45 | 2.325 | 2.39 | 245896.0 |
| Dec 03, 2024 | 2.48 | 2.48 | 2.38 | 2.405 | 20065.00 |
| Dec 02, 2024 | 2.36 | 2.48 | 2.34 | 2.45 | 38263.00 |
| Nov 29, 2024 | 2.40 | 2.50 | 2.32 | 2.44 | 329084.0 |
| Nov 27, 2024 | 2.50 | 2.587 | 2.00 | 2.435 | 286368.0 |
| Nov 26, 2024 | 2.70 | 2.79 | 2.50 | 2.53 | 71369.00 |
| Nov 25, 2024 | 2.68 | 2.74 | 2.62 | 2.64 | 8526.00 |
| Nov 22, 2024 | 2.65 | 2.798 | 2.650 | 2.71 | 45978.00 |
| Nov 21, 2024 | 2.80 | 2.80 | 2.56 | 2.67 | 11335.00 |
| Nov 20, 2024 | 2.50 | 2.78 | 2.50 | 2.75 | 25364.00 |
| Nov 19, 2024 | 2.66 | 2.76 | 2.526 | 2.55 | 26929.00 |
| Nov 18, 2024 | 2.67 | 2.69 | 2.63 | 2.63 | 6695.00 |
| Nov 15, 2024 | 2.74 | 2.79 | 2.60 | 2.61 | 57289.00 |
| Nov 14, 2024 | 2.94 | 2.988 | 2.70 | 2.80 | 702100.0 |
| Nov 13, 2024 | 3.00 | 3.00 | 2.810 | 2.94 | 30737.00 |
| Nov 12, 2024 | 2.94 | 3.04 | 2.91 | 3.00 | 155024.0 |
| Nov 11, 2024 | 2.80 | 2.95 | 2.79 | 2.90 | 25345.00 |
| Nov 08, 2024 | 2.81 | 2.91 | 2.725 | 2.86 | 20950.00 |
| Nov 07, 2024 | 2.875 | 2.90 | 2.82 | 2.84 | 11074.00 |
| Nov 06, 2024 | 2.90 | 2.92 | 2.75 | 2.84 | 29621.00 |
| Nov 05, 2024 | 2.925 | 2.96 | 2.85 | 2.92 | 21624.00 |
| Nov 04, 2024 | 2.96 | 2.96 | 2.885 | 2.90 | 21566.00 |
| Nov 01, 2024 | 3.01 | 3.04 | 2.900 | 3.00 | 27219.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
2.08
Minimum
Nov 08 2023
130.00
Maximum
Feb 16 2021
31.57
Average
20.80
Median
May 27 2022
Price Benchmarks
| Fonar Corp | 15.68 |
| XWELL Inc | 1.43 |
| ProPhase Labs Inc | 0.7016 |
| Applied DNA Sciences Inc | 0.2033 |
| Veracyte Inc | 42.45 |
Price Related Metrics
| PS Ratio | 38.31 |
| Price to Book Value | 4.369 |
| Earnings Yield | -180.2% |
| Market Cap | 42.42M |